Shares of Talkspace, Inc. (NASDAQ:TALK – Get Free Report) have received an average recommendation of “Moderate Buy” from the eight brokerages that are currently covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a sell rating, one has assigned a hold rating, three have assigned a buy rating and two have assigned a strong buy rating to the company. The average 1 year price objective among brokers that have covered the stock in the last year is $4.8750.
Several brokerages have issued reports on TALK. Weiss Ratings restated a “sell (d)” rating on shares of Talkspace in a research report on Wednesday, October 8th. Zacks Research lowered Talkspace from a “hold” rating to a “strong sell” rating in a research report on Monday, October 6th.
Get Our Latest Analysis on Talkspace
Institutional Inflows and Outflows
Talkspace Stock Performance
Shares of NASDAQ:TALK opened at $2.90 on Tuesday. The company has a market capitalization of $485.66 million, a PE ratio of 145.07 and a beta of 1.12. Talkspace has a 52-week low of $2.22 and a 52-week high of $4.36. The company has a fifty day moving average of $2.71 and a 200-day moving average of $2.77.
Talkspace (NASDAQ:TALK – Get Free Report) last released its quarterly earnings results on Thursday, October 30th. The company reported $0.02 earnings per share for the quarter, hitting the consensus estimate of $0.02. Talkspace had a return on equity of 2.48% and a net margin of 1.41%.The company had revenue of $59.38 million for the quarter, compared to analysts’ expectations of $57.45 million. Talkspace has set its FY 2025 guidance at EPS. On average, equities analysts forecast that Talkspace will post 0.08 EPS for the current fiscal year.
About Talkspace
Talkspace, Inc operates as a virtual behavioral healthcare company in the United States. The company offers psychotherapy and psychiatry services through its platform to individuals, enterprises, and health plans and employee assistance programs. It provides text, audio, and video-based psychotherapy from licensed therapists.
Featured Stories
- Five stocks we like better than Talkspace
- What is an Earnings Surprise?
- Why Microsoft’s Post-Earnings Dip Is a Buy-the-Pause Moment
- Utilities Stocks Explained – How and Why to Invest in Utilities
- NVIDIA’s Billion-Dollar Bet Puts Nokia Back in the Growth Game
- Insider Buying Explained: What Investors Need to Know
- Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations
Receive News & Ratings for Talkspace Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Talkspace and related companies with MarketBeat.com's FREE daily email newsletter.
